Performance of a cost-effective olfactory test to evaluate hyposmia in Parkinson's disease patients
Arquivos de Neuro-Psiquiatria · 01.05.2024 · 82 (05) · 001-006
DOI: 10.1055/s-0044-1787139 ↗Kurz gefasst
Fachartikel in der Zeitschrift Arquivos de Neuro-Psiquiatria, erschienen am 01.05.2024. Verfasst von Josevânia Fulgêncio de Lima Arruda und 6 weiteren Autor:innen. Beteiligte Einrichtung: Universidade Federal do Rio de Janeiro, Hospital Universitário Clementino Fraga Filho, Serviço de Neurologia Prof. Sérgio Novis, Rio de Janeiro RJ, B…. Hauptthemen laut MEDLINE: Parkinson Disease, COVID-19, Anosmia. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Parkinson's disease (PD) causes motor and non-motor symptoms such as hyposmia, which is evaluated through olfactory tests in the clinical practice.
Objective
To assess the feasibility of using the modified Connecticut Chemosensory Clinical Research Center (mCCCRC) olfactory test and to compare its performance with the Sniffin' Sticks-12 (SS-12, Burghart Messtechnik GmbH, Wedel, Germany) test.
Methods
A transversal case-control study in which the patients were divided into the PD group (PDG) and the control group (CG). The cost and difficulty in handling substances to produce the mCCCRC test kits were evaluated. Sociodemographic characteristics, smoking habits, past coronavirus disease 2019 (COVID-19) infections, self-perception of odor sense, and cognition through the Montreal Cognitive Assessment (MoCA) were also evaluated. The PDG was scored by part III of the Unified Parkinson's Disease Rating Scale (UPDRS-III) and the Hoehn and Yahr Scale (H&Y) scale. Correlations were assessed through the Spearman rank correlation coefficient test (ρ, or rho).
Results
The mCCCRC test was easily manufactured and handled at a cost ten times lower compared with the SS-12. The groups (PDG: n = 34; CG: n = 38) were similar in terms of age, sex, level of schooling, smoking habits, and history of COVID-19. The tests results showed moderate correlation (rho = 0.65; p < 0.0001). The CG presented better cognitive performance and scored better in both tests (p < 0.0001). There was a tendency for a negative correlation with age, but good correlation with the MoCA (p = 0.0029). The results of the PDG group showed no correlation with olfactory results and motor performance or disease duration. The self-perception of hyposmia was low in both groups.
Conclusion
The mCCCRC is an easy-to-apply and inexpensive method that demonstrated a similar performance to that of the SS-12 in evaluating olfaction in PD patients and healthy controls.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Universidade Federal do Rio de Janeiro, Hospital Universitário Clementino Fraga Filho, Serviço de Neurologia Prof. Sérgio Novis, Rio de Janeiro RJ, Brazil.
ORCID-Profile: Josevânia Fulgêncio de Lima Arruda, Liene Duarte Silva, Rodrigo Tavares Brisson, Gabriel de Castro Micheli, Marco Antônio Sales Dantas de Lima, Ana Lucia Zuma de Rosso, Rita de Cássia Leite Fernandes
Zitieren
APA
Arruda, J. F. L., Silva, L. D., Brisson, R. T., Micheli, G. C., Lima, M. A. S. D., Rosso, A. L. Z., & Fernandes, R. C. L. (2024). Performance of a cost-effective olfactory test to evaluate hyposmia in Parkinson's disease patients. Arquivos de Neuro-Psiquiatria, 82(05), 001-006. https://doi.org/10.1055/s-0044-1787139
Vancouver
Arruda JFL, Silva LD, Brisson RT, Micheli GC, Lima MASD, Rosso ALZ, et al. Performance of a cost-effective olfactory test to evaluate hyposmia in Parkinson's disease patients. Arquivos de Neuro-Psiquiatria. 2024;82(05):001-006. doi:10.1055/s-0044-1787139
BibTeX
@article{Arruda2024,
author = {Arruda, Josevânia Fulgêncio de Lima and Silva, Liene Duarte and Brisson, Rodrigo Tavares and Micheli, Gabriel de Castro and Lima, Marco Antônio Sales Dantas de and Rosso, Ana Lucia Zuma de and Fernandes, Rita de Cássia Leite},
title = {Performance of a cost-effective olfactory test to evaluate hyposmia in Parkinson's disease patients},
journal = {Arquivos de Neuro-Psiquiatria},
year = {2024},
volume = {82},
number = {05},
pages = {001--006},
doi = {10.1055/s-0044-1787139}
}
EUVIMED